Published guidance, NICE advice and quality standards | Guidance

Showing 431 to 440 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer	TA584	5 June 2019	5 June 2019
Enzalutamide for hormone-relapsed non-metastatic prostate cancer	TA580	15 May 2019	15 May 2019
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma	TA577	24 April 2019	24 April 2019
Certolizumab pegol for treating moderate to severe plaque psoriasis	TA574	17 April 2019	17 April 2019
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)	TA576	17 April 2019	17 April 2019
Tildrakizumab for treating moderate to severe plaque psoriasis	TA575	17 April 2019	17 April 2019
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes	TA572	27 March 2019	27 March 2019
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib	TA571	20 March 2019	20 March 2019
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)	TA570	20 March 2019	20 March 2019
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer	TA569	20 March 2019	20 March 2019